This page shows the latest Ra Pharma news and features for those working in and with pharma, biotech and healthcare.
for patients with early RA that may change the course of disease and reduce the likelihood of disability. ... The anti-TNFs are currently the three biggest-selling pharma products in the world with combined revenues last year of around $30bn.
According to Sanofi, the MOBILITY study, involving 306 participants, demonstrated that patients treated with sarilumab in combination with a standard RA treatment, methotrexate (MTX), achieved a significant improvement in signs and ... symptoms of
The UK's National Institute for Health and Clinical Excellence (NICE) has issued final guidance recommending Centocor Ortho Biotech's rheumatoid arthritis (RA) drug Simponi (golimumab) for use on the NHS ... The drug is recommended for adults with severe
AstraZeneca (AZ) has announced the beginning of phase III clinical trial development for rheumatoid arthritis (RA) treatment fostamatinib. ... Syk is a form of tyrosine kinase protein that can lead to the inflammatory conditions of RA when functioning
Belgium's Galapagos has acquired the full rights to an investigational arthritis compound from GSK and is commencing a phase I clinical trial - PMLiVE
Pfizer has decided to scrap development of a drug for a very large market – rheumatoid arthritis (RA). ... Trubion noted that Pfizer intends to continue development of another RA product that is part of the collaboration, SBI-087.
More from news
Approximately 0 fully matching, plus 10 partially matching documents found.
For an indepth analysis of these deals, read'Pharma deals during April 2013'. ... 210+. Ra Pharma/ Merck &Co. Collaboration. Extreme Diversity platform to develop Cyclomimetic candidates for protein targets in multiple therapeutic areas.
Humira (Adalimumab). unknown. Dong-A Pharma. Meiji Seika Pharma. RA. S Korea. ... This decreased profit margins of domestic pharma manufacturers by an average of 3.4 per cent.
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
shape the RA market of tomorrow and how companies can best position themselves for future success. ... Topics to be covered include:. The European RA market. Current status and market situation of JAK inhibitors (key EU5 countries).
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...